Journal
CURRENT OPINION IN VIROLOGY
Volume 5, Issue -, Pages 91-97Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coviro.2014.03.001
Keywords
-
Categories
Funding
- National Natural Science Foundation of China (NSFC) [81021003, 31030030, 81030032/H19]
- Grand SAMP
- T project of China Health and Family Planning Commission [2013ZX10004608-002, 2012ZX10004201-009, 2013ZX10001004]
- intramural special grant for influenza virus research from the Chinese Academy of Sciences [KJZD-EW-L09]
- Innovative Research Group of the National Natural Science Foundation of China [81321063]
Ask authors/readers for more resources
Human infections by the newly reassorted avian influenza A (H7N9) virus were reported for the first time in early 2013, and the virus was confirmed to be a low pathogenic avian influenza virus in poultry. Because continuously reported cases have been increasing since the summer of 2013, this novel virus poses a potential threat to public health in China and is attracting broad attention worldwide. In this review, we summarize and discuss the characteristics of the H7N9 virus revealed by the recent timely studies from the perspectives of epidemiology, host preference, clinical manifestations, immunopathogenesis, drug resistance, vaccine development, and burden of disease. This knowledge about the novel avian-origin H7N9 virus will provide a useful reference for clinical interventions of human infections and help to rapidly pave the way to develop an efficient and safe vaccine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available